[SYRE] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
30-Sep-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -19.72%
YoY- -81.03%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 174 1,399 0 0 0 1,261 1,149 -26.98%
PBT -18,443 -20,281 -18,033 -21,573 -11,917 -7,874 -6,238 19.79%
Tax -209 26 0 0 0 0 0 -
NP -18,234 -20,307 -18,033 -21,573 -11,917 -7,874 -6,238 19.56%
Tax Rate - - - - - - - -
Total Cost 18,408 21,706 18,033 21,573 11,917 9,135 7,387 16.42%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin -10,479.31 -1,451.54 0.00 0.00 0.00 -624.43 -542.91 63.74%
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -4.84 -7.72 -7.24 -16.40 -13.55 -12.00 -11.70 -13.67%
EPS Diluted -4.84 -7.72 -7.24 -16.40 -13.55 -12.00 -11.70 -13.67%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.